WB
CGON icon

WesBanco Bank’s CG Oncology CGON Stock Holding History

WesBanco Bank’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Hold
22,300
– – 0.04% 309
2026
Q1 		$1.51M Sell
22,300
-4,700
-17% -$266K 0.04% 287
2025
Q4 		$1.12M Hold
27,000
– – 0.03% 344
2025
Q3 		$1.09M Hold
27,000
– – 0.03% 355
2025
Q2 		$702K Buy
+27,000
New +$651K 0.02% 407

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WesBanco Bank's CGON Position: Q2 2026 in Review

WesBanco Bank held its CG Oncology (CGON) position steady in Q2 2026 at 22,300 shares worth $1.58M. The position accounts for 0.04% of the portfolio, ranked #309.

WesBanco Bank first reported a position in CGON in Q2 2025 and has held it in 5 quarters since. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • WesBanco Bank held 22,300 shares of CG Oncology worth $1.58M as of Q2 2026.
  • WesBanco Bank left its CG Oncology share count unchanged in Q2 2026.
  • CG Oncology made up 0.04% of WesBanco Bank's portfolio in Q2 2026, its #309 holding.
  • WesBanco Bank first reported a position in CG Oncology in Q2 2025 and has held it in 5 quarters since.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.